Experts develop immune-enhancing therapies to target tuberculosis
HMN 2024 – Scanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB. Credit: NIAID Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body’s own immune system to target tuberculosis, with hopes that they could tackle even the drug-resistant forms of the disease. In a presentation at this year’s ESCMID Read More
Read More